Copyright Manisses Communications Group 1993
Alcoholism & Drug Abuse Week
April 5, 1993
LOAD-DATE-MDX: December 29, 1993
SECTION: Vol. 5 ; No. 14 ; Pg. 6; ISSN: 1042-1394
LENGTH: 296 words
HEADLINE: Three NIDA research grants available; National Institute on Drug Abuse
BODY: The National Institute on Drug Abuse (NIDA) is soliciting proposals for studies on comorbidity in drug abusers and developing medications to treat addictions.
NIDA’s Drug Abuse Treatment Outcome Study (DATOS) includes plans fo r performing a large-scale, three-year study on co-occurring psychiatric conditions among drug users and the reliability of the DATOS survey i n identifying psychiatric conditions. NIDA’s request, NIH-NOIDA-3-6201, seeks organizations that can perform the study.
NIDA also seeks requests from organizations interested in competing for a contract to study addiction treatment medications, including ibogaine , buprenorphine and naltrindole. The goal of request NOIDA-3-8301 is to assure the purity of the drugs used by NIDA researchers in their work.
Request NOIDA-3-8302 is also research-related. NIDA is looking for an organization that can develop assessment tools to examine the activit y of various chemicals and how they interact with amine receptors in the b rain.
Both of the research grants require Drug Enforcement Agency authori zation to handle controlled substances.
Applications for all three NIDA programs are due approximately 45 d ays after their March 22 issuance date. The announcements appeared in the March 19 NIH Guide. For information on Be “DATOS Psychiatric Comorbidity Study,” contact Johnnie Rice, Contract Specialist, NIDA, 5600 Fishers Lane, Room 10-49, Rockville, MD 20857. fax (301) 443-7595.
For information on the “Analytical Chemist ry and Stability Testing of Treatment Drugs” proposal or the “In-Vitro Biog enic; Amine Receptor Testing for Potential Cocaine Treatment Medications” proposal, contact Brenda Brooks, Contract Specialist, at NIDA (same address as above).